577 related articles for article (PubMed ID: 30685528)
1. Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.
Liu QQ; Lu K; Zhu HM; Kong SL; Yuan JM; Zhang GH; Chen NY; Gu CX; Pan CX; Mo DL; Su GF
Eur J Med Chem; 2019 Mar; 165():293-308. PubMed ID: 30685528
[TBL] [Abstract][Full Text] [Related]
2. 2-Styryl-4-aminoquinazoline derivatives as potent DNA-cleavage, p53-activation and in vivo effective anticancer agents.
Wei XW; Yuan JM; Huang WY; Chen NY; Li XJ; Pan CX; Mo DL; Su GF
Eur J Med Chem; 2020 Jan; 186():111851. PubMed ID: 31761381
[TBL] [Abstract][Full Text] [Related]
3. Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis.
Yuan JM; Wei K; Zhang GH; Chen NY; Wei XW; Pan CX; Mo DL; Su GF
Eur J Med Chem; 2019 May; 169():144-158. PubMed ID: 30875505
[TBL] [Abstract][Full Text] [Related]
4. Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers.
Abbass EM; Khalil AK; Mohamed MM; Eissa IH; El-Naggar AM
Bioorg Chem; 2020 Nov; 104():104255. PubMed ID: 32927130
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors.
Ibrahim MK; Taghour MS; Metwaly AM; Belal A; Mehany ABM; Elhendawy MA; Radwan MM; Yassin AM; El-Deeb NM; Hafez EE; ElSohly MA; Eissa IH
Eur J Med Chem; 2018 Jul; 155():117-134. PubMed ID: 29885574
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of novel HDAC inhibitors with a 3-(benzazol-2-yl)quinoxaline framework.
Yang Y; Liu Q; Wang X; Gou S
Bioorg Med Chem Lett; 2023 May; 88():129305. PubMed ID: 37116762
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
El-Adl K; El-Helby AA; Sakr H; Elwan A
Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
[TBL] [Abstract][Full Text] [Related]
8. Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors.
Eissa IH; Metwaly AM; Belal A; Mehany ABM; Ayyad RR; El-Adl K; Mahdy HA; Taghour MS; El-Gamal KMA; El-Sawah ME; Elmetwally SA; Elhendawy MA; Radwan MM; ElSohly MA
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900123. PubMed ID: 31463953
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anticancer properties of novel oxa/azaspiro[4,5]trienones as potent apoptosis inducers through mitochondrial disruption.
Yugandhar D; Nayak VL; Archana S; Shekar KC; Srivastava AK
Eur J Med Chem; 2015 Aug; 101():348-57. PubMed ID: 26163220
[TBL] [Abstract][Full Text] [Related]
10. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
11. Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers.
El Newahie AMS; Nissan YM; Ismail NSM; Abou El Ella DA; Khojah SM; Abouzid KAM
Molecules; 2019 Mar; 24(6):. PubMed ID: 30934622
[TBL] [Abstract][Full Text] [Related]
12. New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis.
Alsaif NA; Dahab MA; Alanazi MM; Obaidullah AJ; Al-Mehizia AA; Alanazi MM; Aldawas S; Mahdy HA; Elkady H
Bioorg Chem; 2021 May; 110():104807. PubMed ID: 33721808
[TBL] [Abstract][Full Text] [Related]
13. 3-Arylamino-quinoxaline-2-carboxamides inhibit the PI3K/Akt/mTOR signaling pathways to activate P53 and induce apoptosis.
Chen NY; Lu K; Yuan JM; Li XJ; Gu ZY; Pan CX; Mo DL; Su GF
Bioorg Chem; 2021 Sep; 114():105101. PubMed ID: 34175723
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anticancer activity as inhibitors of c-Met kinase.
Abbas HA; Al-Marhabi AR; Eissa SI; Ammar YA
Bioorg Med Chem; 2015 Oct; 23(20):6560-72. PubMed ID: 26420384
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel β-pinene-based thiazole derivatives as potential anticancer agents via mitochondrial-mediated apoptosis pathway.
Wang Y; Wu C; Zhang Q; Shan Y; Gu W; Wang S
Bioorg Chem; 2019 Mar; 84():468-477. PubMed ID: 30576910
[TBL] [Abstract][Full Text] [Related]
16. Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents.
Tseng CH; Chen YR; Tzeng CC; Liu W; Chou CK; Chiu CC; Chen YL
Eur J Med Chem; 2016 Jan; 108():258-273. PubMed ID: 26686931
[TBL] [Abstract][Full Text] [Related]
17. Induction of Cell Death in Human A549 Cells Using 3-(Quinoxaline-3-yl) Prop-2-ynyl Methanosulphonate and 3-(Quinoxaline-3-yl) Prop-2-yn-1-ol.
Sibiya MA; Raphoko L; Mangokoana D; Makola R; Nxumalo W; Matsebatlela TM
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678061
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA.
Liang GB; Wei JH; Jiang H; Huang RZ; Qin JT; Wang HL; Wang HS; Zhang Y
Eur J Med Chem; 2021 Jan; 210():112951. PubMed ID: 33109400
[TBL] [Abstract][Full Text] [Related]
19. Pyridazino[1,6-b]quinazolinones as new anticancer scaffold: Synthesis, DNA intercalation, topoisomerase I inhibition and antitumor evaluation in vitro and in vivo.
Huang WY; Zhang XR; Lyu L; Wang SQ; Zhang XT
Bioorg Chem; 2020 Jun; 99():103814. PubMed ID: 32278208
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of quinoxaline derivatives as tubulin polymerization inhibitors that elevate intracellular ROS and triggers apoptosis via mitochondrial pathway.
Qi J; Huang J; Zhou X; Luo W; Xie J; Niu L; Yan Z; Luo Y; Men Y; Chen Y; Zhang Y; Wang J
Chem Biol Drug Des; 2019 Apr; 93(4):617-627. PubMed ID: 30635972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]